Teva To Acquire Theramex in €265M Deal
Under the terms of the transaction announced Thursday, Teva will pay €265 million to Merck KGaA's Merck Serono SA unit when the deal closes. In addition, Merck Serono will be eligible to receive performance-based milestone payments, the details of which were not disclosed.
The agreement also will give Teva distribution rights for Theramex...
To view the full article, register now.